Literature DB >> 33227525

European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Lung cancer.

Thierry Berghmans1, Yolande Lievens2, Matti Aapro3, Anne-Marie Baird4, Marc Beishon5, Fiorella Calabrese6, Csaba Dégi7, Roberto C Delgado Bolton8, Mina Gaga9, József Lövey10, Andrea Luciani11, Philippe Pereira12, Helmut Prosch13, Marika Saar14, Michael Shackcloth15, Geertje Tabak-Houwaard16, Alberto Costa17, Philip Poortmans18.   

Abstract

European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC) are written by experts representing all disciplines involved in cancer care in Europe. They give patients, health professionals, managers and policymakers a guide to essential care throughout the patient journey. Lung cancer is the leading cause of cancer mortality and has a wide variation in treatment and outcomes in Europe. It is a major healthcare burden and has complex diagnosis and treatment challenges. Care must only be carried out in lung cancer units or centres that have a core multidisciplinary team (MDT) and an extended team of health professionals detailed here. Such units are far from universal in European countries. To meet European aspirations for comprehensive cancer control, healthcare organisations must consider the requirements in this paper, paying particular attention to multidisciplinarity and patient-centred pathways from diagnosis, to treatment, to survivorship.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Audit; Cancer centre; Cancer unit; Care pathways; Essential requirements; Europe; Guidelines; Health inequalities; Healthcare system; Lung cancer; Multidisciplinary; Multidisciplinary team; Organisation of care; Patient information; Patient-centred; Quality; Quality assurance

Mesh:

Year:  2020        PMID: 33227525     DOI: 10.1016/j.lungcan.2020.08.017

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  9 in total

Review 1.  Lung Cancer Treatment: From Tradition to Innovation.

Authors:  Giuseppe Mangiameli; Ugo Cioffi; Alberto Testori
Journal:  Front Oncol       Date:  2022-05-27       Impact factor: 5.738

Review 2.  Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group.

Authors:  M Guirado; A Sanchez-Hernandez; L Pijuan; C Teixido; A Gómez-Caamaño; Á Cilleruelo-Ramos
Journal:  Clin Transl Oncol       Date:  2021-10-19       Impact factor: 3.405

Review 3.  Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0.

Authors:  Sofia C Vaz; Judit A Adam; Roberto C Delgado Bolton; Pierre Vera; Wouter van Elmpt; Ken Herrmann; Rodney J Hicks; Yolande Lievens; Andrea Santos; Heiko Schöder; Bernard Dubray; Dimitris Visvikis; Esther G C Troost; Lioe-Fee de Geus-Oei
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-01-13       Impact factor: 10.057

4.  Effect of Refined Perioperative Nursing on the Efficacy of Noninvasive Ventilation in Elderly Patients with Lung Cancer and Respiratory Failure.

Authors:  Li Huang; Chun Feng
Journal:  J Oncol       Date:  2022-06-15       Impact factor: 4.501

5.  Application Effect and Prognosis of High-Quality Nursing in the Whole Process of Nursing in Lung Cancer Surgery.

Authors:  Ling Mei; Yan Xu; Qingtong Shi; Chen Wu
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-17       Impact factor: 2.650

6.  Effects of Bevacizumab Combined with Chemotherapy on CT, CyFRA21-1, and ProGRP and Prognosis of Lung Cancer Patients under Nursing Intervention.

Authors:  Chao Xi; Hong Jiang; Yinling Xue; Yongmei Lv; Chao Wang
Journal:  Comput Math Methods Med       Date:  2022-07-14       Impact factor: 2.809

7.  Use of information and communication technologies (ICTs) in cancer multidisciplinary team meetings: an explorative study based on EU healthcare professionals.

Authors:  Joan Prades; Cristina Coll-Ortega; Lissandra Dal Lago; Karolien Goffin; Eugen Javor; Claudio Lombardo; Johan de Munter; Jordi Ponce; Daniele Regge; Ramón Salazar; Vincenzo Valentini; Josep M Borras
Journal:  BMJ Open       Date:  2022-10-06       Impact factor: 3.006

Review 8.  Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG-PET/CT external beam radiation treatment planning in lung cancer.

Authors:  Sofia C Vaz; Judit A Adam; Roberto C Delgado Bolton; Pierre Vera; Wouter van Elmpt; Ken Herrmann; Rodney J Hicks; Yolande Lievens; Andrea Santos; Heiko Schöder; Bernard Dubray; Dimitris Visvikis; Esther G C Troost; Lioe-Fee de Geus-Oei
Journal:  Radiother Oncol       Date:  2022-01-20       Impact factor: 6.901

Review 9.  Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach.

Authors:  Sanjay Popat; Neal Navani; Keith M Kerr; Egbert F Smit; Timothy J P Batchelor; Paul Van Schil; Suresh Senan; Fiona McDonald
Journal:  Oncologist       Date:  2020-11-21       Impact factor: 5.837

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.